Teva Asks Supreme Court For Stay On MS Drug Patent Ruling
Teva Pharmaceuticals USA Inc. on Monday asked the U.S. Supreme Court to stay a Federal Circuit decision that invalidated several patents covering Copaxone, claiming the ruling would sap the multiple sclerosis...To view the full article, register now.
Already a subscriber? Click here to view full article